Cheng Y, Wang J, Yu Y, Wang Q, et al. Phase I/II Study of Tifcemalimab, an Anti-B and T-lymphocyte Attenuator Antibody, in Combination with Toripalimab in Previously Treated Advanced Lung Cancer. Clin Cancer Res 2025 May 16. doi: 10.1158/1078-0432.CCR-25-0022.
PMID: 40378060